Identification of eosinophil lineage-committed progenitors in the murine bone marrow

Journal of Experimental Medicine

Volumn 201, Issue 12, 2005, Pages 1891-1897

  Iwasaki, Hiromi ^a,b   Mizuno, Shin Ichi ^a   Mayfield, Robin ^c   Shigematsu, Hirokazu ^a   Arinobu, Yojiro ^a   Seed, Brian ^c   Gurish, Michael F ^d   Takatsu, Kiyoshi ^e   Akashi, Koichi ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL MARKER; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 9; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL LINEAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; EXPERIMENTAL MOUSE; FLUORESCENCE ACTIVATED CELL SORTING; GRANULOCYTE; HELMINTHIASIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HOST PARASITE INTERACTION; IN VIVO STUDY; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; CELL LINEAGE; DNA PRIMERS; DNA-BINDING PROTEINS; EOSINOPHILS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; FLOW CYTOMETRY; GATA1 TRANSCRIPTION FACTOR; GRANULOCYTE PRECURSOR CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 22344443951     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20050548     Document Type: Article

References (30)

1. Rothenberg, M.E., A. Mishra, E.B. Brandt, and S.P. Hogan. 2001. Gastrointestinal eosinophils. Immunol. Rev. 179:139-155.
2. Rothenberg, M.E. 1998. Eosinophilia. N. Engl. J. Med. 338:1592-1600.
3. Denburg, J.A., S. Telizyn, H. Messner, B. Lim, N. Jamal, S.J. Ackerman, G.J. Gleich, and J. Bienenstock. 1985. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood. 66:312-318.
4. Nakahata, T., S.S. Spicer, and M. Ogawa. 1982. Clonal origin of human erythro-eosinophilic colonies in culture. Blood. 59:857-864.
5. Clutterbuck, E.J., E.M. Hirst, C.J. Sanderson, J.M. Wang, A. Rambaldi, A. Biondi, Z.G. Chen, and A. Mantovani. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood. 73:1504-1512.
6. Nakahata, T., K. Tsuji, A. Ishiguro, O. Ando, N. Norose, K. Koike, and T. Akabane. 1985. Single-cell origin of human mixed hemopoietic colonies expressing various combinations of cell lineages. Blood. 65:1010-1016.
7. Suda, T., J. Suda, and M. Ogawa. 1984. Disparate differentiation in mouse hemopoietic colonies derived from paired progenitors. Proc. Natl. Acad. Sci. USA. 81:2520-2524.
8. Sanderson, C.J. 1992. Interleukin-5, eosinophils, and disease. Blood. 79: 3101-3109.
9. Foster, P.S., S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183: 195-201.
10. Coffman, R.L., B.W. Seymour, S. Hudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 245:308-310.
11. Dent, L.A., M. Strath, A.L. Mellor, and C.J. Sanderson. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172: 1425-1431.
12. Tominaga, A., S. Takaki, N. Koyama, S. Katoh, R. Matsumoto, M. Migita, Y. Hitoshi, Y. Hosoya, S. Yamauchi, Y. Kanai, et al. 1991. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173:429-437.
13. McNagny, K., and T. Graf. 2002. Making eosinophils through subtle shifts in transcription factor expression. J. Exp. Med. 195:F43-47.
14. Kulessa, H., J. Frampton, and T. Graf. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 9:1250-1262.
15. Yamaguchi, Y., S.J. Ackerman, N. Minegishi, M. Takiguchi, M. Yamamoto, and T. Suda. 1998. Mechanisms of transcription in eosinophils: GATA-1, but not GATA-2, transactivates the promoter of the eosinophil granule major basic protein gene. Blood. 91:3447-3458.
16. Hirasawa, R., R. Shimizu, S. Takahashi, M. Osawa, S. Takayanagi, Y. Kato, M. Onodera, N. Minegishi, M. Yamamoto, K. Fukao, et al. 2002. Essential and instructive roles of GATA factors in eosinophil development. J. Exp. Med. 195:1379-1386.
17. Heyworth, C., S. Pearson, G. May, and T. Enver. 2002. Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO J. 21:3770-3781.
18. Iwasaki, H., S. Mizuno, R.A. Wells, A.B. Cantor, S. Watanabe, and K. Akashi. 2003. GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. Immunity. 19:451-462.
19. Kondo, M., I.L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:661-672.
20. Akashi, K., D. Traver, T. Miyamoto, and I.L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:193-197.
21. Jasinski, M., P. Keller, Y. Fujiwara, S.H. Orkin, and M. Bessler. 2001. GATA1-Cre mediates Piga gene inactivation in the erythroid/megakaryocytic lineage and leads to circulating red cells with a partial deficiency in glycosyl phosphatidylinositol-linked proteins (paroxysmal nocturnal hemoglobinuria type II cells). Blood. 98:2248-2255.
22. Basten, A., M.H. Boyer, and P.B. Beeson. 1970. Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J. Exp. Med. 131:1271-1287.
23. Querfurth, E., M. Schuster, H. Kulessa, J.D. Crispino, G. Doderlein, S.H. Orkin, T. Graf, and C. Nerlov. 2000. Antagonism between C/EBPbeta and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors. Genes Dev. 14:2515-2525.
24. Boyce, J.A., D. Friend, R. Matsumoto, K.F. Austen, and W.F. Owen. 1995. Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. J. Exp. Med. 182:49-57.
25. Weil, S.C., and M.A. Hrisinko. 1987. A hybrid eosinophilic-basophilic granulocyte in chronic granulocytic leukemia. Am. J. Clin. Pathol. 87: 66-70.
26. Takagi, M., T. Hara, M. Ichihara, K. Takatsu, and A. Miyajima. 1995. Multi-colony stimulating activity of interleukin 5 (IL-5) on hematopoietic progenitors from transgenic mice that express IL-5 receptor alpha subunit constitutively. J. Exp. Med. 181:889-899.
27. Yamaguchi, Y., T. Matsui, T. Kasahara, S. Etoh, A. Tominaga, K. Takatsu, Y. Miura, and T. Suda. 1990. In vivo changes of hemopoietic progenitors and the expression of the interleukin 5 gene in eosinophilic mice infected with Toxocara canis. Exp. Hematol. 18:1152-1157.
28. Shardonofsky, F.R., J. Venzor, III, R. Barrios, K.P. Leong, and D.P. Huston. 1999. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma. J. Allergy Clin. Immunol. 104:215-221.
29. Garrett, J.K., S.C. Jameson, B. Thomson, M.H. Collins, L.E. Wagoner, D.K. Freese, L.A. Beck, J.A. Boyce, A.H. Filipovich, J.M. Villanueva, et al. 2004. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J. Allergy Clin. Immunol. 113:115-119.
30. Yamaguchi, N., Y. Hitoshi, S. Mita, Y. Hosoya, Y. Murata, Y. Kikuchi, A. Tominaga, and K. Takatsu. 1990. Characterization of the murine interleukin 5 receptor by using a monoclonal antibody. Int. Immunol. 2:181-187.